Chinese Journal of Pharmacovigilance ›› 2012, Vol. 9 ›› Issue (4): 224-226.

• Orginal Article • Previous Articles     Next Articles

How Medical Institutions to Do Adverse Drug Reaction Monitoring Well

LIU Cui-li, TIAN Chun-hua, FENG Hong-yun   

  1. Center for Drug Reevaluation, SFDA, Beijing 100045, China
  • Online:2012-04-10 Published:2015-08-10

Abstract: The new revision of Provisions for Adverse Drug Reaciton Reporting and Monitoring was promulgated on May 4 2011. The provisions clearled definy the responsibilities of the medical institutions who are one of the main body of adverse drug reaction reporting.Combined with the provisions, this article aims to introduce how the medical institutions to do adverse drug reaction monitoring well during the new period of monitoring.

Key words: Medical institutions, Provisions for Adverse Drug Reaciton Reporting and Monitoring, adverse drug reaction monitoring